Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 3/20 | 0.56 |
| ▸ | MTOR | P42345 | 3/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.52 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.52 |
| ▸ | CCNK | O75909 | 1/20 | 0.44 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 10/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 9/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 9/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 9/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 9/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 9/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 9/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 9/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 9/20 | 0.43 |
| ▸ | CDK2 | P24941 | 3/20 | 0.43 |
| ▸ | CDK1 | P06493 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4572146 | 1.00 | PIK3CA (0.56) | PIK3CAMTORADORA2AADORA2BADORA1 | |
| SCHEMBL244324 | 1.00 | PIK3CA (0.56) | PIK3CAMTORADORA2AADORA2BADORA1 | |
| SCHEMBL19261367 | 0.88 | PIK3CA (0.54) | PIK3CAMTORADORA2AADORA2BADORA1 | |
| SCHEMBL5019512 | 0.88 | PIK3CA (0.71) | PIK3CAMTORADORA2AADORA2BADORA1 | |
| SCHEMBL9924586 | 0.85 | PIK3CA (0.58) | PIK3CAMTORCCNKCDK12HDAC1 | |
| SCHEMBL12187039 | 0.85 | PIK3CA (0.58) | PIK3CAMTORCCNKCDK12HDAC1 | |
| SCHEMBL27408140 | 0.85 | PIK3CA (0.58) | PIK3CAMTORCCNKCDK12HDAC1 | |
| SCHEMBL15679247 | 0.85 | PIK3CA (0.58) | PIK3CAMTORCCNKCDK12HDAC1 | |
| SCHEMBL19618136 | 0.85 | PIK3CA (0.53) | PIK3CAMTORCCNKCDK12HDAC1 | |
| SCHEMBL8055477 | 0.85 | PIK3CA (0.80) | PIK3CAMTORHDAC1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120059000-A1 | CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS FOR KINASE MODULATION | INFINITY PHARMACEUTICALS, INC. | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059000-A1 | CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS FOR KINASE MODULATION | MAP3K13, AKT3, PIK3CA | PIK3CA 3/4885MTOR 60/4885ADORA2A 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.